Correction: Leveraging T cell co-stimulation for enhanced therapeutic efficacy of trispecific antibodies targeting prostate cancer

Saved in:
Bibliographic Details
Format: Article
Language:English
Published: BMJ Publishing Group 2025-03-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/13/3/e010140corr1.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849733828932796416
collection DOAJ
format Article
id doaj-art-5a99f3239ef64cc196e331050ca9bcb0
institution DOAJ
issn 2051-1426
language English
publishDate 2025-03-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj-art-5a99f3239ef64cc196e331050ca9bcb02025-08-20T03:07:57ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262025-03-0113310.1136/jitc-2024-010140corr1Correction: Leveraging T cell co-stimulation for enhanced therapeutic efficacy of trispecific antibodies targeting prostate cancerhttps://jitc.bmj.com/content/13/3/e010140corr1.full
spellingShingle Correction: Leveraging T cell co-stimulation for enhanced therapeutic efficacy of trispecific antibodies targeting prostate cancer
Journal for ImmunoTherapy of Cancer
title Correction: Leveraging T cell co-stimulation for enhanced therapeutic efficacy of trispecific antibodies targeting prostate cancer
title_full Correction: Leveraging T cell co-stimulation for enhanced therapeutic efficacy of trispecific antibodies targeting prostate cancer
title_fullStr Correction: Leveraging T cell co-stimulation for enhanced therapeutic efficacy of trispecific antibodies targeting prostate cancer
title_full_unstemmed Correction: Leveraging T cell co-stimulation for enhanced therapeutic efficacy of trispecific antibodies targeting prostate cancer
title_short Correction: Leveraging T cell co-stimulation for enhanced therapeutic efficacy of trispecific antibodies targeting prostate cancer
title_sort correction leveraging t cell co stimulation for enhanced therapeutic efficacy of trispecific antibodies targeting prostate cancer
url https://jitc.bmj.com/content/13/3/e010140corr1.full